Urinary cysteinyl leukotriene E4significantly increases during pain in children and adults with sickle cell disease-Reference-Cited by-同舟云学术

Urinary cysteinyl leukotriene E4significantly increases during pain in children and adults with sickle cell disease

Published:2009-04 Issue:4 Volume:84 Page:231-233
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Field Joshua J.,Strunk Robert C.,Knight-Perry Jessica E.,Blinder Morey A.,Townsend R. Reid,DeBaun Michael R.

Publisher

Wiley

Subject

Hematology

Reference16 articles.

1. Pain in sickle cell disease. Rates and risk factors;Platt;N Engl J Med,1991

2. Leukotrienes;Peters-Golden;N Engl J Med,2007

3. Measurement of leukotrienes in humans;Kumlin;Am J Respir Crit Care Med,2000

4. Cysteinyl leukotrienes in the urine of patients with liver diseases;Uemura;Hepatology,1994

5. Analysis of cysteinyl leukotrienes in human urine: Enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome;Huber;Eur J Clin Invest,1989

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trial;Trials;2021-10-10

2. Phase 2 trial of montelukast for prevention of pain in sickle cell disease;Blood Advances;2020-03-24

3. Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation;Clinica Chimica Acta;2019-06

4. A physicians survey assessing management of pulmonary airway involvement in sickle cell disease;Pediatric Pulmonology;2019-04-22

5. Advances in new drug therapies for the management of sickle cell disease;Expert Opinion on Orphan Drugs;2018-05-04